Physician

Michael Chaouki Gemayel

According to 2025 Medicare claims, Michael Gemayel (NPI: 1194258624) practices ophthalmology in the Detroit-Dearborn-Livonia, MI market, with the plurality of this provider's patient population coming from Wayne, MI. This provider's primary affiliated billing organization is MICHIGAN RETINA CENTER, PC (NPI: 1164960571; TIN: 384025028) and primary practice location at 48124-1715.

Gemayel's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 285 traditional Medicare patients, billed 7,039 HCPCS/CPT codes, and received $453,492 in Medicare payments. The top billing code was 92004 (New patient complete exam of visual system). Part D data shows 509 prescription claims across 212 beneficiaries totaling $7,343 in drug costs, led by Prednisolone Acetate (Prednisolone Acetate). Open Payments data shows 7 records totaling $291. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider has fewer than 5 years of reported Medicare Part B carrier billing data, so a reliable trend cannot be assigned. Concurrently, Part D prescription costs started with an early spike, then settled into a lower baseline, moving from $6,696 to $7,343. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$227K$453K2022 Medicare payment: $1,330 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $49,770 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $453,492 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
2019N/RN/RN/R
2020N/RN/RN/R
2021N/RN/RN/R
20222134$1,330
202399714$49,770
20242857,039$453,492

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$3.7K$7.5K2018 Drug cost: $6,696 (USD; Tot_Drug_Cst)2019 Drug cost: $7,480 (USD; Tot_Drug_Cst)2020 Drug cost: $2,495 (USD; Tot_Drug_Cst)2021 Drug cost: $2,407 (USD; Tot_Drug_Cst)2022 Drug cost: $2,803 (USD; Tot_Drug_Cst)2023 Drug cost: $3,329 (USD; Tot_Drug_Cst)2024 Drug cost: $7,343 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
201843112$6,696
201942116$7,480
20203486$2,495
20211343$2,407
20221663$2,803
202348107$3,329
2024212509$7,343

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
92004New patient complete exam of visual system113113$109
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more81136$101
92014Established patient complete exam of visual system132222$92
92134Imaging of retina259631$30
92201Extended exam of the back part of the eye with retinal drawing220470$19

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Prednisolone AcetatePrednisolone Acetate861,793$2,856
Gentamicin SulfateGentamicin Sulfate2685,131$2,005
Ketorolac TromethamineKetorolac Tromethamine781,931$1,435
Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat221,645$349
Brimonidine TartrateBrimonidine Tartrate11408$69

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.7$291Apellis Pharmaceuticals, Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Michael Chaouki Gemayel?

Tedicare shows public-source Medicare data for Michael Chaouki Gemayel (NPI 1194258624), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Michael Chaouki Gemayel have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Michael Chaouki Gemayel?

Michael Chaouki Gemayel is linked to MICHIGAN RETINA CENTER, PC (billing NPI 1164960571) in the available physician profile data.

Does Michael Chaouki Gemayel have Open Payments data?

Michael Chaouki Gemayel has 7 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.